OncoZenge AB
0
0
+SEK0.00+0% 00:00 Today
Statistics
Day High
-
Day Low
-
52W High
-
52W Low
-
Volume
-
Avg. Volume
-
Mkt Cap
0
P/E Ratio
-
Dividend Yield
-
Dividend
-
Earnings
20MayExpected
Q1 2026
999
333
-333
-999
Expected EPS
N/A
Actual EPS
N/A
Competitors
This list is an analysis based on recent market events. It's not an investment recommendation.
About
OncoZenge AB (publ) operates as a pharmaceutical company with a focus on developing medical solutions that offer supportive care for cancer patients. A significant product in its pipeline is BupiZenge, which has successfully completed Phase 2 clinical trials for the management of oral mucositis. This company was established in 2020 and conducts its operations from its headquarters in Bromma, Sweden. Notably, OncoZenge AB (publ) is a subsidiary entity of Moberg Pharma AB (publ).
Show more...
CEO
Stian Kildal
Employees
1
Country
Sweden
ISIN
SE0030264628
Listings
0 Comments
Share your thoughts
FAQ
What is OncoZenge AB stock ticker?▼
Depending on the exchange, the stock ticker may vary. For instance, on Stockholm Exchange exchange OncoZenge AB stocks are traded under the ticker ONCOZ-BTA.ST.
How many employees does OncoZenge AB have?▼
As of September 05, 2026, the company has 1 employees.
In which sector is OncoZenge AB located?▼
OncoZenge AB operates in the Health & Wellness sector.
When did OncoZenge AB complete a stock split?▼
OncoZenge AB has not had any recent stock splits.
Where is OncoZenge AB headquartered?▼
OncoZenge AB is headquartered in Bromma, Sweden.